{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:57:01Z","timestamp":1788436621542,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim Care Resp Med"],"DOI":"10.1038\/npjpcrm.2014.88","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T15:34:03Z","timestamp":1420731243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze"],"prefix":"10.1038","volume":"25","author":[{"given":"Wim M","family":"van Aalderen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garcia-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Lenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dekhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"BFnpjpcrm201488_CR1","unstructured":"GINA report. Global Strategy for the Diagnosis and Management of Asthma in children. Updated 2009 and 2012 www.ginasthma.org."},{"key":"BFnpjpcrm201488_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ppul.20591","volume":"42","author":"AG Kaditis","year":"2007","unstructured":"Kaditis AG, Winnie G, Syrogiannopoulos GA . Anti-inflammatory pharmacotherapy for wheezing in preschool children. Pediatr Pulmonol 2007; 42: 407\u2013420.","journal-title":"Pediatr Pulmonol"},{"key":"BFnpjpcrm201488_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jaci.2010.01.034","volume":"125","author":"I Amirav","year":"2010","unstructured":"Amirav I, Newhouse MT, Minocchieri S, Castro-Rodriguez JA, Sch\u00fcepp KG . Factors that affect the efficacy of inhaled corticosteroids for infants and young children. J Allergy CIin Immunol 2010; 125: 1206\u20131211.","journal-title":"J Allergy CIin Immunol"},{"key":"BFnpjpcrm201488_CR4","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1183\/09031936.00166410","volume":"37","author":"BL Laube","year":"2011","unstructured":"Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P et al. What the pulmonary specialist should know about new inhalation therapies. Eur Respir J 2011; 37: 1308\u20131331.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm201488_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3109\/02770903.2013.783064","volume":"50","author":"WG Ammari","year":"2013","unstructured":"Ammari WG, Chrystin H . Optimizing the inhalation flow and technique through metered dose inhalers of asthmatic adults and children attending a community pharmacy. J Asthma 2013; 50: 505\u2013513.","journal-title":"J Asthma"},{"key":"BFnpjpcrm201488_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/02770900701815834","volume":"45","author":"NJ Van de Berg","year":"2008","unstructured":"Hagmolen of ten Have W, Van de Berg NJ, Bindels PJ, van Aalderen WM, van der Palen J . Assessment of inhalation technique in children in general practice: increased risk of incorrect performance with new device. J Asthma 2008; 45: 67\u201371.","journal-title":"J Asthma"},{"key":"BFnpjpcrm201488_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4104\/pcrj.2010.00043","volume":"19","author":"S Pedersen","year":"2010","unstructured":"Pedersen S, Dubus JC, Crompton GK, ADMIT Working Group. The ADMIT series issues in inhalation therapy. 5) Inhaler selection in children with asthma. Prim Care Respir J 2010; 19: 209\u2013216.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm201488_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/02770903.2013.876650","volume":"51","author":"CM Harnett","year":"2014","unstructured":"Harnett CM, Hunt EB, Bowen BR, O'Connell OJ, Edgeworth DM, Mitchell P et al. A study to assess inhaler technique and its potential impact on asthma control in patients attending an asthma clinic. J Asthma 2014; 51: 440\u2013445.","journal-title":"J Asthma"},{"key":"BFnpjpcrm201488_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1378\/chest.127.1.335","volume":"127","author":"MB Dolovich","year":"2005","unstructured":"Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL et al. Device selection and outcomes of aerosol therapy: Evidence based guidelines: American college of chest physicians\/American college of Asthma, Allergy, and Immunology. Chest 2005; 127: 335\u2013371.","journal-title":"Chest"},{"key":"BFnpjpcrm201488_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta5260","volume":"5","author":"D Brocklebank","year":"2001","unstructured":"Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L et al. Comparison of effectiveness of inhaler devices in asthma and chronic obstructive airway disease: a systematic review of the literature. Health Technol Assess 2001; 5: 1\u2013149.","journal-title":"Health Technol Assess"},{"key":"BFnpjpcrm201488_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rmed.2012.09.017","volume":"107","author":"D Price","year":"2013","unstructured":"Inhaler Error Steering Committee, Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 2013; 107: 37\u201346.","journal-title":"Respir Med"},{"key":"BFnpjpcrm201488_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1651-2227.2002.tb01688.x","volume":"91","author":"AW Kamps","year":"2002","unstructured":"Kamps AW, Brand PL, Roorda RJ . Determinants of correct inhalation technique in children attending a hospital based asthma clinic. Acta Paediatr 2002; 91: 159\u2013163.","journal-title":"Acta Paediatr"},{"key":"BFnpjpcrm201488_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1378\/chest.105.1.111","volume":"105","author":"NA Hanania","year":"1994","unstructured":"Hanania NA, Wittman R, Kesten S, Chapman KR . Medical personnel\u2019s knowledge of and ability to use inhaling devices. Chest 1994; 105: 111\u2013116.","journal-title":"Chest"},{"key":"BFnpjpcrm201488_CR14","first-page":"1346","volume":"50","author":"JL Rau","year":"2005","unstructured":"Rau JL . Determinants of patient adherence to an aerosol regimen. Respir Care. 2005; 50: 1346\u20131356.","journal-title":"Respir Care."},{"key":"BFnpjpcrm201488_CR15","doi-asserted-by":"publisher","first-page":"65S","DOI":"10.1378\/chest.130.1_suppl.65S","volume":"130","author":"R Horne","year":"2006","unstructured":"Horne R . Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006; 130(1 Suppl): 65S\u201372S.","journal-title":"Chest"},{"key":"BFnpjpcrm201488_CR16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1203229","volume":"367","author":"HW Kelly","year":"2012","unstructured":"Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P CAMP Research Group et al. Effect of inhaled glucocorticoids on adult height. N Engl J Med 2012; 367: 904\u2013912.","journal-title":"N Engl J Med"},{"key":"BFnpjpcrm201488_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.pec.2007.11.007","volume":"70","author":"BG Bokhour","year":"2008","unstructured":"Bokhour BG, Cohn ES, Cort\u00e9s DE, Yinusa-Nyahkoon LS, Hook JM, Smith LA et al. Patterns of concordance and non-concordance with clinician recommendations and parents' explanatory models in children with asthma. Patient Educ Couns 2008; 70: 376\u2013385.","journal-title":"Patient Educ Couns"},{"key":"BFnpjpcrm201488_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.anai.2011.01.016","volume":"106","author":"AG Weinstein","year":"2011","unstructured":"Weinstein AG . The potential of asthma adherence management to enhance asthma guidelines. Ann Allergy Asthma Immunol 2011; 106: 283\u2013291.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"BFnpjpcrm201488_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1001\/archinte.168.13.1387","volume":"168","author":"LB Mauksch","year":"2008","unstructured":"Mauksch LB, Dugdale DC, Dodson S, Epstein R . Relationship, communication, and efficiency in the medical encounter: creating a clinical model from a literature review. Arch Intern Med 2008; 168: 1387\u20131395.","journal-title":"Arch Intern Med"},{"key":"BFnpjpcrm201488_CR20","first-page":"383","volume":"64","author":"G Murakami","year":"1990","unstructured":"Murakami G, Igarashi T, Adachi Y, Matsuno M, Adachi Y, Sawai M et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy 1990; 64: 383\u2013387.","journal-title":"Ann Allergy"},{"key":"BFnpjpcrm201488_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/adc.81.2.163","volume":"81","author":"R Iles","year":"1999","unstructured":"Iles R, Lister P, Edmunds AT . Crying significantly reduces absorption of aerosolised drugs in infants. Arch Dis Child 1999; 81: 163\u2013165.","journal-title":"Arch Dis Child"},{"key":"BFnpjpcrm201488_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1542\/peds.108.2.389","volume":"108","author":"I Amirav","year":"2001","unstructured":"Amirav I, Newhouse MT . Aerosol therapy with valved holding chambers in young children: importance of the face mask seal. Pediatrics 2001; 108: 389\u2013394.","journal-title":"Pediatrics"},{"key":"BFnpjpcrm201488_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ppul.20767","volume":"43","author":"I Amirav","year":"2008","unstructured":"Amirav I, Newhouse MT . Review of optimal characteristics of face-masks for valve-holding chambers (VHC). Pediatr Pulmonol 2008; 43: 268\u2013274.","journal-title":"Pediatr Pulmonol"},{"key":"BFnpjpcrm201488_CR24","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1183\/09031936.94.07122185","volume":"7","author":"HL Chua","year":"1994","unstructured":"Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994; 7: 2185\u20132191.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm201488_CR25","first-page":"921","volume":"119","author":"DW Cockroft","year":"1979","unstructured":"Cockroft DW, MacCormack DW, Tarlo SM, Hargreave FE, Pengelly LD . Nasal airway inspiratory resistance. Am Rev Respir Dis 1979; 119: 921\u2013926.","journal-title":"Am Rev Respir Dis"},{"issue":"suppl","key":"BFnpjpcrm201488_CR26","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1089\/08942680150506312","volume":"14","author":"PH Howarth","year":"2001","unstructured":"Howarth PH . Why particle size should affect clinical response to inhaled therapy. J Aerosol Med 2001; 14 (suppl): S27\u2013S34.","journal-title":"J Aerosol Med"},{"key":"BFnpjpcrm201488_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1398-9995.1986.tb00287.x","volume":"41","author":"S Pedersen","year":"1986","unstructured":"Pedersen S, Frost L, Anfred T . Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986; 41: 118\u2013124.","journal-title":"Allergy"},{"key":"BFnpjpcrm201488_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000029259","volume":"65","author":"V Plaza","year":"1998","unstructured":"Plaza V, Sanchis J . Medical personnel and patient skill in the use of metered dose inhalers: a multicentric study. CESEA Group.. Respiration 1998; 65: 195\u2013198.","journal-title":"Respiration"},{"key":"BFnpjpcrm201488_CR29","first-page":"234","volume":"34","author":"S Pedersen","year":"1987","unstructured":"Pedersen S . Inhaler use in children with asthma. Dan Med Bull 1987; 34: 234\u2013249.","journal-title":"Dan Med Bull"},{"key":"BFnpjpcrm201488_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1183\/09031936.00051106","volume":"29","author":"CM Roller","year":"2007","unstructured":"Roller CM, Zhang G, Troedson RG, Leach CL, Le Sou\u00ebf PN . Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children. Eur Respir J 2007; 29: 299\u2013366.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm201488_CR31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/thx.46.10.712","volume":"46","author":"SP Newman","year":"1991","unstructured":"Newman SP, Weisz AW, Talaee N, Clarke SW . Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712\u2013716.","journal-title":"Thorax"},{"key":"BFnpjpcrm201488_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/jamp.2009.0783","volume":"23","author":"CL Leach","year":"2010","unstructured":"Leach CL, Colice GL . A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathold times. J Aerosol Med Pulm Drug Deliv 2010; 23: 355\u2013361.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"BFnpjpcrm201488_CR33","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/adc.67.5.580","volume":"67","author":"ML Everard","year":"1992","unstructured":"Everard ML, Clark AR, Milner AD . Drug delivery from holding chambers with attached face mask. Arch Dis Child 1992; 67: 580\u2013585.","journal-title":"Arch Dis Child"},{"key":"BFnpjpcrm201488_CR34","doi-asserted-by":"publisher","first-page":"e1493","DOI":"10.1542\/peds.2010-1377","volume":"126","author":"A Schultz","year":"2010","unstructured":"Schultz A, Le Sou\u00ebf TJ, Venter A, Zhang G, Devadason SG, Le Sou\u00ebf PN . Aerosol inhalation from spacers and valved holding chambers requires few tidal breaths for children. Pediatrics 2010; 126: e1493\u2013e1498.","journal-title":"Pediatrics"},{"key":"BFnpjpcrm201488_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1034\/j.1399-3003.1999.13d15.x","volume":"13","author":"HM Janssens","year":"1999","unstructured":"Janssens HM, Devadason SG, Hop WJC, Lesoueff PN, De Jongste JC, Tiddens HA . Variability in aerosol delivery via spacer devices in young asthmatic children in daily life. Eur Respir J 1999; 13: 787\u2013791.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm201488_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/(SICI)1099-0496(200005)29:5<389::AID-PPUL8>3.0.CO;2-3","volume":"29","author":"JH Wildhaber","year":"2000","unstructured":"Wildhaber JH, Janssen HM, Pierart F, Dore ND, Devadason SG, LeSou\u00ebf PN . High-percentage lung delivery in children from detergent-treated spacers. Pediatr Pulmonol 2000; 29: 389\u2013393.","journal-title":"Pediatr Pulmonol"},{"key":"BFnpjpcrm201488_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/adc.71.3.217","volume":"71","author":"L Agertoft","year":"1994","unstructured":"Agertoft L, Pedersen S . Influence of spacer device on drug delivery to young children with asthma. Arch Dis Child 1994; 71: 217\u2013220.","journal-title":"Arch Dis Child"},{"key":"BFnpjpcrm201488_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1183\/09031936.03.00087803","volume":"21","author":"SG Devadason","year":"2003","unstructured":"Devadason SG, Huang T, Walker S, Trodson R, le Sou\u00ebf PN . Distribution of technetium-99m-labelled QVAR TM delivered using an autohaler TM device in children. Eur Respir J 2003; 21: 1007\u20131011.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm201488_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/rmed.1999.0678","volume":"94","author":"IS Farmer","year":"2000","unstructured":"Farmer IS, Middle M, Savic J, Perrin VL, Herdman MJ . Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA134a) propellants both delivered via the EasibreatheTM inhaler for the treatment of paediatric asthma. Respir Med 2000; 94: 57\u201363.","journal-title":"Respir Med"},{"key":"BFnpjpcrm201488_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/jam.1996.9.215","volume":"9","author":"DL Ross","year":"1996","unstructured":"Ross DL, Schulz RK . Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler products (pMDI). J Aerosol Med 1996; 9: 215\u2013226.","journal-title":"J Aerosol Med"},{"key":"BFnpjpcrm201488_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/adc.65.3.308","volume":"65","author":"S Pedersen","year":"1990","unstructured":"Pedersen S, Hansen OR, Fuglsang G . Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990; 65: 308\u2013310.","journal-title":"Arch Dis Child"},{"key":"BFnpjpcrm201488_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0954-6111(98)90040-3","volume":"92","author":"LS Hill","year":"1998","unstructured":"Hill LS, Slater AL . A comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med 1998; 92: 105\u2013110.","journal-title":"Respir Med"},{"key":"BFnpjpcrm201488_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1164\/rccm.200302-200OC","volume":"168","author":"L Agertoft","year":"2003","unstructured":"Agertoft L, Pedersen S . Lung deposition and systemic availability of budesonide Turbuhaler and fluticasone Diskus in children. Am J Respir Crit Care Med 2003; 168: 779\u2013782.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFnpjpcrm201488_CR44","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1183\/09031936.98.11051111","volume":"11","author":"H Bisgaard","year":"1998","unstructured":"Bisgaard H, Klug B, Sumby BS, Burnell PK . Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma. Eur Respir J 1998; 11: 1111\u20131115.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm201488_CR45","first-page":"S7","volume":"7","author":"B Fyrnys","year":"2001","unstructured":"Fyrnys B, Stang N, Wolf-Heuss E . Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device. Curr Opin Pulm Med 2001; 7: S7\u2013S11.","journal-title":"Curr Opin Pulm Med"},{"key":"BFnpjpcrm201488_CR46","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.rmed.2004.03.024","volume":"98","author":"C Vogelberg","year":"2004","unstructured":"Vogelberg C, Kremer HJ, Ellers-Lenz B, Engel M, Maus J, Conrad F et al. Clinical evaluation of the peak inspiratory flow generated by asthmatic children through the Novolizer. Respir Med 2004; 98: 924\u2013931.","journal-title":"Respir Med"},{"key":"BFnpjpcrm201488_CR47","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1164\/ajrccm.154.3.8810618","volume":"154","author":"IM Adcock","year":"1996","unstructured":"Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ . Glucocorticosteroid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996; 154: 771\u2013782.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFnpjpcrm201488_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/299444a0","volume":"299","author":"PJ Barnes","year":"1982","unstructured":"Barnes PJ, Basbaum CB, Nadel JA, Roberts JM . Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. Nature 1982; 299: 444\u2013447.","journal-title":"Nature"},{"key":"BFnpjpcrm201488_CR49","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jaci.2009.07.062","volume":"124","author":"FW Gelfland","year":"2009","unstructured":"Gelfland FW, Kraft M . The importance and features of distal airways in children and adults. J Allergy Clin Immunol 2009; 124: S84\u2013S87.","journal-title":"J Allergy Clin Immunol"},{"key":"BFnpjpcrm201488_CR50","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1183\/09031936.98.12061346","volume":"12","author":"CL Leach","year":"1998","unstructured":"Leach CL, Davidson PJ, Boudreau RJ . Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998; 12: 1346\u20131353.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm201488_CR51","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1368-5031.2004.00274.x","volume":"58","author":"CP Van Schayck","year":"2004","unstructured":"Van Schayck CP, Donnell D . The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone dipropionate extrafine aerosol) in asthma (Part 2): clinical experience in children. Int J Clin Pract 2004; 58: 786\u2013794.","journal-title":"Int J Clin Pract"},{"key":"BFnpjpcrm201488_CR52","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.rmed.2006.11.020","volume":"101","author":"WM Van Aalderen","year":"2007","unstructured":"Van Aalderen WM, Price D, De Baets FM, Price J . Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma. Respir Med 2007; 101: 1585\u20131593.","journal-title":"Respir Med"},{"key":"BFnpjpcrm201488_CR53","doi-asserted-by":"crossref","unstructured":"Van Aalderen WM, Grigg J, Colice G, Martin RJ, Roche N, Dorinsky P, et al. Real-world effectiveness of extrafine hydrofluoroalkane beclomethasone versus fluticasone propionate and inhaled corticosteroid\/long acting beta-agonist as step-up therapy in paediatric asthma. CIPP XII 2013 Abstracts. Available from http:\/\/rirl.org\/index.php?option=com_phocadownload&view=category&download=85:submission_comparing%20paediatric%20step-up%20therapies_sg14jan2013&id=1:public-downloads.","DOI":"10.1016\/S1526-0542(13)70137-4"},{"key":"BFnpjpcrm201488_CR54","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1651-2227.1998.tb01548.x","volume":"87","author":"L Agertoft","year":"1998","unstructured":"Agertoft L, Pedersen S . Importance of training for correct Turbuhaler use in preschool children. Acta Paediatr 1998; 87: 842\u2013847.","journal-title":"Acta Paediatr"},{"key":"BFnpjpcrm201488_CR55","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0022-3476(96)70357-8","volume":"128","author":"A Tal","year":"1996","unstructured":"Tal A, Golan H, Grauer N, Aviram M, Albin D, Quastel MR . Deposition pattern of readiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in Young children with airway obstruction. J Pediatr 1996; 128: 479\u2013484.","journal-title":"J Pediatr"},{"key":"BFnpjpcrm201488_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0022-3476(99)70323-9","volume":"135","author":"JH Wildhaber","year":"1999","unstructured":"Wildhaber JH, Dore N, Wilson JM, Devadason SG, le Sou\u00ebf PN . Inhalation therapy in asthma: nebulizer or pressurised metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 1999; 135: 28\u201333.","journal-title":"J Pediatr"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201488","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:03:45Z","timestamp":1672923825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm201488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,17]]}},"alternative-id":["BFnpjpcrm201488"],"URL":"https:\/\/doi.org\/10.1038\/npjpcrm.2014.88","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]},"assertion":[{"value":"24 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"WMvA is a member of the advisory boards of Mundipharma, Astra Zeneca, AbbVie and Teva. LGM has no conflict of interest. MG has no conflict of interest. WL has no conflict of interest. S. Pedersen has received consultancy fees from Glaxo Smith Kline and Boehringer Ingelheim, and fees for lectures for Glaxo Smth Kline and Boehringer Ingelheim. PND has received reimbursements for attending symposia, fees for speaking, organising educational events, funds for research or fees for consulting from AstraZeneca, Boehringer-Ingelheim, Chiesi, Merck Sharp & Dohme, Mundipharma, Novartis, Takeda, Almirall and Teva. He is a member of the Aerosol Drug Management Improvement Team (ADMIT). DP has board membership at Almirall, Astra Zeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Merck, Mundipharma, Medapharma, Novartis, Napp, Nycomed, Pfizer, Sandoz and Teva. <i>Consultancy<\/i>: Almirall, Amgen, Astra Zeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Merck, Mundipharma, Medapharma, Novartis, Napp, Nycomed, Pfizer, Sandoz and Teva. <i>Grants\/Grants Pending<\/i>: UK National Health Service, Aerocrine, Astra Zeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Meda, Merck, Mundipharma, Novartis, Nycomed, Orion, Pfizer, Takeda, Teva and Zentiva. <i>Payments for lectures\/speaking<\/i>: Almirall, AstraZeneca, Activaero, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline, Kyorin, Novartis, Medapharma, Merck, Mundipharma, Pfizer, SkyePharma, Takeda and Teva. <i>Payment for manuscript preparation<\/i>: Merck, Mundipharma and Teva. <i>Patents (planned, pending or issued)<\/i>: AKL Ltd. <i>Payment for the development of educational materials<\/i>: GlaxoSmithKline. <i>Stock\/Stock options<\/i>: Shares in AKL Ltd, which produces phytopharmaceuticals and owns 80% of Research in Real Life Ltd and its subsidiary social enterprise Optimum Patient Care. <i>Payment for travel\/accommodations\/meeting expenses<\/i>: Aerocrine, Boehringer Ingelheim, Napp, Novartis, Mundipharma and Teva. <i>Funding for patient enrolment or completion of research<\/i>: Chiesi, Almirall, Zentiva and Teva. <i>Peer reviewer for grant committees<\/i>: Medical Research Council (2012), Efficacy and Mechanism Evaluation programme (2012), HTA (2012). <i>Contract research<\/i>: Aerocrine, AKL Ltd, Almirall, Boehringer Ingelheim, Chiesi, Mundipharma, Medapharma, Novartis, Napp, Orion, Takeda, Zentiva.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14088"}}